Last updated: November 27, 2023
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Corona Virus
Treatment
blood samples, urine samples and nasopharyngeal swabs
Clinical Study ID
NCT05557539
2021/30DEC/543
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 years or over
- Patient or legal representative have provided informed consent
- Cases: Reverse-transcriptase polymerase chain reaction (RT-PCR) confirmed symptomaticSARS-CoV-2 infection.
- Controls : (1) Patient presenting with hypoxemic respiratory failure diagnosed by thetreating physician as being from infectious origin; (2) SARS-CoV-2 infection excludedby RT-PCR and deemed non-probable by the treating physician.
- Healthy controls : Patients presenting without acute respiratory failure (ie. SpO2 >93%); (2) no RT-PCR or antigen rapid test proven SARS-CoV-2 infection within the last 6 months; (3) no active respiratory tract infection.
Exclusion
Exclusion Criteria:
- For all: (1) <18 years old ; (2)unwilling to provide informed consent; (3) pregnancyat the time of inclusion
- For cases: Asymptomatic infection
- For controls: COVID-19 diagnosed by RT-PCR or suspect according to the treatingphysician at the time of inclusion,
- For health controls: Acute or chronic respiratory failure.
Study Design
Total Participants: 275
Treatment Group(s): 1
Primary Treatment: blood samples, urine samples and nasopharyngeal swabs
Phase:
Study Start date:
February 07, 2022
Estimated Completion Date:
September 30, 2024
Study Description
Connect with a study center
Cliniques Universitaires Saint-Luc
Brussels, 1200
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.